JCVI: Efficient Cross-priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent.
 
 
Section Banner

Publications

Citation

Lev A, Dimberu P, Das SR, Maynard JC, Nicchitta CV, Bennink JR, Yewdell JW

Efficient Cross-priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent.

Journal of immunology (Baltimore, Md. : 1950). 2009 Oct 01; 183: 4205-10.

External Citation

Abstract

Cross-priming, the activation of naive CD8+ T cells by dendritic cells presenting Ags synthesized by other cells, is believed to play an important role in the generation of antiviral and antitumor responses. The molecular mechanism(s) underlying cross-priming remain poorly defined and highly controversial. GRP94 (gp96), an abundant endoplasmic reticulum chaperone with innate immune-activating capacity, has been widely reported to play a major role in cross-priming. In this study, we show that cells whose expression of GRP94 is silenced via transient or stable transfection with GRP94-directed small interfering RNAs demonstrate no reduction in their abilities to generate class I peptide complexes in cultured cells or to prime antiviral CD8+ T cell responses in vivo. In demonstrating the dispensability of GRP94, our finding points to the importance of alternative mechanisms for generation of class I peptide complexes from endogenous and exogenous Ags and immunogens.